Evidence map›Paper›PMID 40427189›Full record

ArticleCancers2025

Synergistic Effects of Cryotherapy and Radiotherapy in Glioblastoma Treatment: Evidence from a Murine Model.

Hélène Cebula, Chrystelle Po, Carole Mura, Benoit Lhermitte, Roberto Luigi Cazzato, Marion Rame, Clara Le Fèvre, Julien Todeschi, Charles-Henry Mallereau, Afshin Gangi and 4 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hélène CebulaDepartment of Neurosurgery, Hautepierre University Hospital, 1, Avenue Molière, 67200 Strasbourg, France.
Chrystelle PoUniversité de Strasbourg, CNRS, ICube UMR 7357, 67000 Strasbourg, France.ORCID 0000-0001-9785-9572
Carole MuraUniversité de Strasbourg, CNRS, ICube UMR 7357, 67000 Strasbourg, France.ORCID 0000-0003-0305-711X
Benoit LhermittePathology Department, University Hospital of Strasbourg, 67098 Strasbourg, France.
Roberto Luigi CazzatoDepartment of Interventional Radiology, University Hospital of Strasbourg, 1, Place de l'Hôpital, 67000 Strasbourg, France.
Marion RameUniversité de Strasbourg, CNRS, ICube UMR 7357, 67000 Strasbourg, France.
Clara Le FèvreDepartment of Radiation Oncology, Institut de Cancérologie Strasbourg Europe (ICANS), UNICANCER, 17 Rue Albert Calmette, 67033 Strasbourg, France.
Julien TodeschiDepartment of Neurosurgery, Hautepierre University Hospital, 1, Avenue Molière, 67200 Strasbourg, France.
Charles-Henry MallereauDepartment of Neurosurgery, Hautepierre University Hospital, 1, Avenue Molière, 67200 Strasbourg, France.
Afshin GangiUniversité de Strasbourg, CNRS, ICube UMR 7357, 67000 Strasbourg, France.ORCID 0000-0002-0952-7760
Georges NoëlUniversité de Strasbourg, CNRS, ICube UMR 7357, 67000 Strasbourg, France.ORCID 0000-0003-4952-5572
Michel de MathelinUniversité de Strasbourg, CNRS, ICube UMR 7357, 67000 Strasbourg, France.
François ProustDepartment of Neurosurgery, Hautepierre University Hospital, 1, Avenue Molière, 67200 Strasbourg, France.
Hélène BurckelUniversité de Strasbourg, CNRS, ICube UMR 7357, 67000 Strasbourg, France.ORCID 0000-0002-9612-5806

Funding

French State Region contract CPER I2MT (2014-2021), R-IRM (2021-2027) and by the European Union through the European Regional Development Fund "FEDER Grand Est" French State Region contract CPER I2MT (2014-2021), R-IRM (2021-2027) and by the European Union through the European Regional Development Fund "FEDER Grand Est"
6 · The paper itself

Abstract

BACKGROUND/

objectivesCryotherapy involves the insertion of cryoprobes into tumors to induce cell destruction through exposure to extremely low temperatures over several minutes. This localized treatment modality may enhance the efficacy of established therapies, such as radiotherapy, particularly for glioblastomas. Our study aimed to provide proof-of-concept for the efficacy of combining cryotherapy and radiotherapy in the treatment of subcutaneous murine brain tumors (GL-261) in immunocompetent C57BL/6 mice.

methodsTumor growth, survival and response were evaluated using MRI and histological analysis.

resultsPartial cryotherapy alone showed no therapeutic efficacy. However, combining cryotherapy with radiotherapy significantly potentiated treatment outcomes. A statistically significant survival benefit was observed in the combined therapy group compared to control, cryotherapy and radiotherapy groups. Notably, 40% of mice receiving the combined treatment exhibited complete responses, with no detectable tumor cells on MRI or histological analysis. Furthermore, MRI-based monitoring revealed that the Apparent Diffusion Coefficient (ADC) map could predict complete response 14 days post-treatment, unlike caliper-based measurements.

conclusionsThese findings suggest that cryotherapy may enhance radiotherapy efficacy, resulting in complete tumor regression in 4 out of 10 cases. ADC distribution may serve as a predictive marker for therapeutic response. However, given the limitations of the model, further studies in orthotopic models are needed to validate these findings and assess their clinical relevance.

Indexed as

apparent diffusion coefficientcryotherapyglioblastomaradiationradiotherapy

Identifiers

PMID40427189
PMCPMC12110222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.